Literature DB >> 19650038

Dual SP/ALDH functionalities refine the human hematopoietic Lin-CD34+CD38- stem/progenitor cell compartment.

Olivier Pierre-Louis1, Denis Clay, Philippe Brunet de la Grange, Istvan Blazsek, Christophe Desterke, Bernadette Guerton, Camille Blondeau, Jean-Valère Malfuson, Marie Prat, Annelise Bennaceur-Griscelli, Jean-Jacques Lataillade, Marie-Caroline Le Bousse-Kerdilès.   

Abstract

Identification of prevalent specific markers is crucial to stem/progenitor cell purification. Determinants such as the surface antigens CD34 and CD38 are traditionally used to analyze and purify hematopoietic stem/progenitor cells (HSCs/HPCs). However, the variable expression of these membrane antigens poses some limitations to their use in HSC/HPC purification. Techniques based on drug/stain efflux through the ATP-binding cassette (ABC)G2 pump (side population [SP] phenotype) or on detection of aldehyde dehydrogenase (ALDH) activity have been independently developed and distinguish the SP and ALDH(Bright) (ALDH(Br)) cell subsets for their phenotype and proliferative capability. In this study, we developed a multiparametric flow cytometric method associating both SP and ALDH activities on human lineage negative (Lin(-)) bone marrow cells and sorted different cell fractions according to their SP/ALDH activity level. We find that Lin(-)CD34(+)CD38(Low/-) cells are found throughout the spectrum of ALDH expression and are enriched especially in ALDH(Br) cells when associated with SP functionality (SP/ALDH(Br) fraction). Furthermore, the SP marker identified G(0) cells in all ALDH fractions, allowing us to sort quiescent cells regardless of ALDH activity. Moreover, we show that, within the Lin(-)CD34(+)CD38(-)ALDH(Br) population, the SP marker identifies cells with higher primitive characteristics, in terms of stemness-related gene expression and in vitro and in vivo proliferative potential, than the Lin(-)CD34(+) CD38(-)ALDH(Br) main population cells. In conclusion, our study shows that the coexpression of SP and ALDH markers refines the Lin(-)CD34(+)CD38(-) hematopoietic compartment and identifies an SP/ALDH(Br) cell subset enriched in quiescent primitive HSCs/HPCs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19650038     DOI: 10.1002/stem.186

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  15 in total

1.  SP/drug efflux functionality of hematopoietic progenitors is controlled by mesenchymal niche through VLA-4/CD44 axis.

Authors:  J-V Malfuson; L Boutin; D Clay; C Thépenier; C Desterke; F Torossian; B Guerton; A Anginot; T de Revel; J-J Lataillade; M-C Le Bousse-Kerdilès
Journal:  Leukemia       Date:  2013-09-03       Impact factor: 11.528

2.  Aging is not associated with bone marrow-resident progenitor cell depletion.

Authors:  Thomas J Povsic; Jiying Zhou; Stacie D Adams; Michael P Bolognesi; David E Attarian; Eric D Peterson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-06-30       Impact factor: 6.053

3.  Characterization of chronic myeloid leukemia stem cells.

Authors:  Jonathan M Gerber; Lu Qin; Jeanne Kowalski; B Douglas Smith; Constance A Griffin; Milada S Vala; Michael I Collector; Brandy Perkins; Marianna Zahurak; William Matsui; Christopher D Gocke; Saul J Sharkis; Hyam I Levitsky; Richard J Jones
Journal:  Am J Hematol       Date:  2011-01       Impact factor: 10.047

4.  Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications.

Authors:  Frédéric Torossian; Bernadette Guerton; Adrienne Anginot; Kylie A Alexander; Christophe Desterke; Sabrina Soave; Hsu-Wen Tseng; Nassim Arouche; Laetitia Boutin; Irina Kulina; Marjorie Salga; Beulah Jose; Allison R Pettit; Denis Clay; Nathalie Rochet; Erica Vlachos; Guillaume Genet; Charlotte Debaud; Philippe Denormandie; François Genet; Natalie A Sims; Sébastien Banzet; Jean-Pierre Levesque; Jean-Jacques Lataillade; Marie-Caroline Le Bousse-Kerdilès
Journal:  JCI Insight       Date:  2017-11-02

5.  Focal adhesion kinase regulates the localization and retention of pro-B cells in bone marrow microenvironments.

Authors:  Shin-Young Park; Peter Wolfram; Kimberly Canty; Brendan Harley; César Nombela-Arrieta; Gregory Pivarnik; John Manis; Hilary E Beggs; Leslie E Silberstein
Journal:  J Immunol       Date:  2012-12-21       Impact factor: 5.422

6.  Further phenotypic characterization of the primitive lineage- CD34+CD38-CD90+CD45RA- hematopoietic stem cell/progenitor cell sub-population isolated from cord blood, mobilized peripheral blood and patients with chronic myelogenous leukemia.

Authors:  D Wisniewski; M Affer; J Willshire; B Clarkson
Journal:  Blood Cancer J       Date:  2011-09-30       Impact factor: 11.037

7.  Markers for characterization of bone marrow multipotential stromal cells.

Authors:  Sally A Boxall; Elena Jones
Journal:  Stem Cells Int       Date:  2012-05-14       Impact factor: 5.443

8.  Aldehyde dehydrogenase and ATP binding cassette transporter G2 (ABCG2) functional assays isolate different populations of prostate stem cells where ABCG2 function selects for cells with increased stem cell activity.

Authors:  Kalyan J Gangavarapu; Gissou Azabdaftari; Carl D Morrison; Austin Miller; Barbara A Foster; Wendy J Huss
Journal:  Stem Cell Res Ther       Date:  2013-10-25       Impact factor: 6.832

9.  Peritoneal milky spots serve as a hypoxic niche and favor gastric cancer stem/progenitor cell peritoneal dissemination through hypoxia-inducible factor 1α.

Authors:  Zhi-Feng Miao; Zhen-Ning Wang; Ting-Ting Zhao; Ying-Ying Xu; Jian Gao; Feng Miao; Hui-Mian Xu
Journal:  Stem Cells       Date:  2014-12       Impact factor: 6.277

10.  Ovarian cancer stem cells are enriched in side population and aldehyde dehydrogenase bright overlapping population.

Authors:  Kazuyo Yasuda; Toshihiko Torigoe; Rena Morita; Takahumi Kuroda; Akari Takahashi; Junichi Matsuzaki; Vitaly Kochin; Hiroko Asanuma; Tadashi Hasegawa; Tsuyoshi Saito; Yoshihiko Hirohashi; Noriyuki Sato
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.